Kids with Dravet Syndrome Aren't Getting Enough Sleep

Article

Sleep disorders are common in children with Dravet syndrome, a genetic epileptic encephalopathy. Researchers call for medicating these young patients.

Dravet syndrome, a genetic epileptic encephalopathy affecting children, commonly comes with sleep problems.

Reporting at the American Epilepsy Society 69th Annual Meeting in Philadelphia, PA, Ingrid Scheffer of Austin Hospital, Melbourne, Australia, and colleagues shared the results of a survey of families in which a child had the syndrome. They concluded many of these kids, and their families, need help.

Sleep Disturbance Scale for Children questionnaires were sent to 89 families (91 children) to ask about nocturnal seizures and the use of sleep medications.

Of 50 questionnaires that were completed, 42% showed a sleep disturbance pattern.

The subscores indicated difficulty falling and staying asleep (42%) sleep-wake transition problems (34%) and sleep breathing disorders (30%). But only 36% of the children were getting medication to help them sleep.

Pulse oximetry measures were available for 15 patients and showed 87% had a higher oxygen desaturation index (greater than 3%). Mean pulse rates in sleep were higher than normative for 33% of the children with oximeters.

That could mean "unrecognized nocturnal seizures," the authors said.

They concluded that more could be done for these children, including "more widespread use" of medication.

"Clinical evaluation and appropriate investigation with polysomnography of sleep is required to delineate the cause and initiate appropriate interventions" for these sleep-deprived children. Not only would that make life easier for both the children and their parents, it "has the potential to ameliorate developmental outcome."

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.